Overview

Evaluate Rituximab in Obtaining PCR (Polymerase Chain Reaction) Negative Leukapheresis Product in Patients With Relapsed Follicular Lymphoma

Status:
Completed

Trial end date:
2015-07-01

Target enrollment:

Participant gender:

Summary

Researchers hope to learn if adding rituximab with high doses of chemotherapy and stem cell transplantation will help patients get rid of their lymphoma cells from the bone marrow and stem cell collections.

Phase:

Phase 2

Details

Lead Sponsor:

University of Kansas
University of Kansas Medical Center

Treatments:

Rituximab